Taurine 1000 mg

Taurine 1000 mg

Jarrow Formulas4.8 (9,186 ratings)
Format:Capsule Quantity: 100 Capsule(s) · 100 servings
Goals

Product analysis

63 out of 100

Taurine 1000 mg offers an affordable supplement with limited support for endurance in trained runners and blood pressure in selected adults.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality20

Taurine quality remains uncertain because its form is not disclosed. The ingredient name alone does not establish how well the preparation is absorbed.

Ingredient Transparency63

The taurine amount is stated, making serving strength easy to check. Its form is undisclosed, limiting comparisons between preparations.

Value For Money100

The price is low relative to the amount of taurine provided. That makes it an economical way to supplement this ingredient.

Customer Satisfaction93

Customer ratings are very positive. Thousands of responses give the favorable feedback a broad base.

Product Focus69

The clearest practical support concerns selected blood-pressure and endurance outcomes. The serving is below the blood-pressure comparison amount, while longer life and routine cleansing benefits remain unestablished.

Format
Capsule
Container
100 Capsule(s)
Per serving
$0.10
Customer rating
4.8 · 9,186 ratings
Report analysis

Goals

Fitness
Impact
High effect
A Ingredient FitD- PathwaysC+ EvidenceA+ Formulation Logic

Taurine has limited, event-specific endurance evidence: a small trial in trained male runners found an improvement in a 3-km time trial after 1 g. This supports cautious expectations for a similar setting, rather than a general strength, hydration or cramp-prevention benefit. Larger servings do not establish a larger effect.

How this product is rated for Fitness

Ingredient fit93

Taurine provides a relevant fitness contribution. The relevant serving amounts reach the saved comparison endpoints; larger amounts do not establish larger benefits.
Goal fit
Taurine gives this product a focused connection to the fitness goal.
Dose adequacy
The relevant serving amounts reach the saved comparison endpoints; larger amounts do not establish larger benefits.

Pathways44

The strongest contribution concerns muscle energy and buffering. Coverage is concentrated in this area.
Depth
The strongest saved contribution concerns muscle energy and buffering, reflecting the relevant ingredients and serving amounts.
Breadth
Substantial coverage is concentrated in one exercise-related area.

Evidence67

Taurine evidence comes from a small running trial, limiting transfer to other populations and activities.
Evidence strength
Taurine evidence comes from a small running trial, limiting transfer to other populations and activities.
Studied preparation
The relevant preparations meet the saved criteria; this does not establish superiority of forms or replicate a complete study regimen.

Formulation logic100

The relevant ingredients have the partners they require, and no configured conflict was identified. Included amounts meet the saved minimum comparison.
Partner coverage
The relevant ingredients can contribute independently or have their required partners present; an additional combination benefit is not established.
Conflicts
No configured ingredient conflict was identified in the supplied findings.
Effective doses
All included ingredients meet the saved minimum amount comparison; this is not proof of benefit from a single serving.
Study evidence
Taurine Supportive 21 studies
Longevity
Impact
Highest effect
A Ingredient FitC- PathwaysB+ EvidenceA+ Formulation Logic
Taurine · 1000 mg

Taurine participates in mitochondrial and antioxidant processes, making it a candidate in aging research. Animal lifespan findings do not establish longer human life or preserved human function. Its declared serving amount receives recognition in the saved findings, while the supplied context leaves a routine human anti-aging benefit unestablished.

How this product is rated for Longevity

Ingredient fit93

The identified amount fully meets the saved amount comparison; that comparison does not establish an effective human anti-aging dose.
Goal fit
The identified ingredients keep the formula focused on the relevant roles, although the product may serve several purposes.
Dose adequacy
The identified amount fully meets the saved amount comparison; that comparison does not establish an effective human anti-aging dose.

Pathways55

The strongest identified connection is cellular energy production. This describes ingredient roles rather than demonstrated slowing of aging.
Depth
The strongest identified connection is cellular energy production. This describes ingredient roles rather than demonstrated slowing of aging.
Breadth
The supplied findings identify cellular energy production.

Evidence82

Taurine provides the strongest evidence contribution in the saved findings, with benefits limited to the conditions and outcomes described above.
Evidence strength
Taurine provides the strongest evidence contribution in the saved findings, with benefits limited to the conditions and outcomes described above.
Studied preparation
The supplied findings recognize the evaluated preparations; this does not broaden their evidence beyond the described outcomes.

Formulation logic100

The evaluated ingredients have no unmet partner requirement or configured conflict.
Partner coverage
The evaluated ingredients have no unmet partner requirement in the supplied findings; this does not establish added benefit from combining them.
Conflicts
No configured ingredient conflict was identified in the supplied findings.
Effective doses
The evaluated ingredients meet the saved minimum amount threshold; this is not proof of an effective anti-aging dose.
Study evidence
Taurine Supportive 3 studies
Liver & Detox
Impact
Moderate effect
A Ingredient FitF PathwaysC EvidenceA+ Formulation Logic
Taurine · 1000 mg

Taurine participates in bile-acid conjugation. Human findings describe changes in bile composition, but they do not demonstrate improved clearance of an identified toxin or a routine cleansing benefit. The 1000 mg amount fully aligns with the saved exposure comparison.

How this product is rated for Liver & Detox

Ingredient fit93

The assessed ingredient is closely aligned with the goal. The assessed amount fully aligns with the saved exposure comparison.
Goal fit
The assessed ingredient is closely aligned with the goal.
Dose adequacy
The assessed amount fully aligns with the saved exposure comparison.

Pathways19

The strongest saved connection concerns conjugation processes. Coverage remains limited across the assessed mechanisms.
Depth
The strongest saved connection concerns conjugation processes.
Breadth
Coverage remains limited across the assessed mechanisms.

Evidence61

Taurine provides the strongest assessed evidence contribution at its amount. The assessed ingredients at adequate amounts match the saved preparation criteria.
Evidence strength
Taurine provides the strongest assessed evidence contribution at its amount.
Studied preparation
The assessed ingredients at adequate amounts match the saved preparation criteria.

Formulation logic100

1 of 1 assessed ingredients meet the saved minimum amount comparison. No assessed conflict was identified.
Partner coverage
The assessed ingredients can contribute independently or have their required partner.
Conflicts
No conflict was identified by the supplied ingredient checks.
Effective doses
1 of 1 assessed ingredients meet the saved minimum amount comparison.
Study evidence
Taurine Supportive 2 studies
Inflammation
Impact
Highest effect
A Ingredient FitD+ PathwaysA- EvidenceA+ Formulation Logic
Taurine · 1000 mg

Taurine has antioxidant mechanisms and some inflammatory-marker findings in selected metabolic-disease populations. Those findings do not establish routine clinical anti-inflammatory benefit in general users. Its declared serving amount receives recognition in the supplied comparisons, but does not by itself establish a matching studied treatment regimen.

How this product is rated for Inflammation

Ingredient fit93

Taurine is the relevant ingredient, with a declared amount for comparison.
Goal fit
The relevant ingredient declarations form a focused comparison for this goal, although clinical applicability remains limited.
Dose adequacy
Declared amounts reach the supplied comparison range; that range is not a proven effective clinical dose.

Pathways53

Inflammatory gene signalling is the strongest assigned route; that assignment does not establish a clinical anti-inflammatory effect.
Depth
Inflammatory gene signalling is the strongest assigned route; that assignment does not establish a clinical anti-inflammatory effect.
Breadth
Only one assigned route reaches the supplied coverage criterion, leaving limited breadth.

Evidence87

Taurine leads the saved evidence finding; selected metabolic-disease biomarker changes do not establish general clinical benefit.
Evidence strength
Taurine leads the saved evidence finding; selected metabolic-disease biomarker changes do not establish general clinical benefit.
Studied preparation
The supplied comparison accepts the relevant preparations; this does not establish equivalence of every formulation or a matching daily regimen.

Formulation logic100

No listed conflict or missing required partner is identified. Amount comparisons do not demonstrate an added benefit from combining ingredients.
Partner coverage
No required partner is missing among the recognized ingredients; this does not establish synergy.
Conflicts
No listed conflict is triggered by the supplied ingredient and amount facts.
Effective doses
All recognized ingredients meet the minimum amount comparison, which is not a proven biological threshold.
Study evidence
Taurine Supportive 12 studies
Cardiovascular Support
Impact
High effect
B+ Ingredient FitD+ PathwaysA- EvidenceA+ Formulation Logic
Taurine · 1000 mg

Taurine may support blood pressure in adults with prehypertension. The supplied trial used 1.6 g daily over 12 weeks, while this 1000 mg serving receives partial amount recognition. That comparison does not establish a proportional response or benefit in people with normal blood pressure, and it does not support rhythm treatment or cardiovascular-event prevention.

How this product is rated for Cardiovascular Support

Ingredient fit83

Taurine is the main recognized ingredient; smaller or unresolved amounts reduce the serving’s contribution.
Goal fit
The recognized ingredients dominate the formula, with links to other goals reducing its cardiovascular specificity.
Dose adequacy
Smaller or unresolved ingredient quantities limit the serving’s amount contribution; partial recognition does not establish a measured dose-response.

Pathways50

The strongest assigned contribution concerns vascular tone and sodium balance. Other cardiovascular mechanisms have less or no assigned coverage.
Depth
The strongest assigned support concerns vascular tone and sodium balance, rather than comprehensive cardiovascular protection.
Breadth
Only vascular tone and sodium balance reaches the coverage threshold.

Evidence88

Taurine leads the evidence findings. The supplied population and preparation limits remain relevant to expectations.
Evidence strength
Taurine provides the leading evidence contribution; its marker findings do not establish prevention of cardiovascular events.
Studied preparation
The counted preparations are recognized as studied, with the population and exposure distinctions described for the relevant ingredients.

Formulation logic100

The counted ingredients have no unmet partner requirement or identified configured conflict; amount thresholds are considered separately.
Partner coverage
No unmet partner requirement is identified for the counted ingredients; combining them does not establish an added benefit.
Conflicts
No configured ingredient conflict was identified.
Effective doses
All counted ingredients clear the minimum amount threshold, which is distinct from a proven effective dose.
Study evidence
Taurine Supportive 24 studies
Muscle Gain
Impact
Lower effect
B- Ingredient FitF PathwaysF EvidenceA+ Formulation Logic
Study evidence
Taurine Not classified

No linked studies yet.

Ingredients

IngredientAmount per servingScore
Taurine
1000 mg 73
Adults 18–50
Report overview
Taurine · 1000 mg OverallScore73
D+ Active Ingredient Quality & BioavailabilityB+ Dose, Safety & Label TransparencyA+ Value
Each serving supplies 1 g of taurine. The full-product price is about $0.10 per gram of taurine.
How this ingredient is rated

Active Ingredient Quality & Bioavailability51

The ingredient is named as taurine, while its source is not identified in the saved facts.
Chemical Form and Purity
The saved facts identify the ingredient as taurine, without a more specific form or purity grade.
Sourcing and Branded Ingredients
The saved facts do not identify the taurine’s brand or source, or the manufacturing origin.
Formulation Cleanliness
A standard excipient or flow agent is recorded in the formula.

Dose, Safety & Label Transparency81

The amount is disclosed at 1 g per serving, but the saved facts contain no testing or certification claim.
Taurine Dosage Potency
Each serving provides 1 g of taurine.
Dose Disclosure
The taurine amount is disclosed as 1 g per serving.
Quality Assurance and Testing
No testing or certification claim is recorded in the saved facts.

Value100

The full-product price is about $0.10 per gram of taurine, based on the disclosed amount.
Price per Gram of Taurine
The full-product price is about $0.10 per gram of taurine, based on the disclosed amount.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Taurine Supplementation Lowers Blood Pressure and Improves Vascular Function in Prehypertension: Randomized, Double-Blind, Placebo-Controlled Study.
    Sun Q; Wang B; Li Y; Sun F; Li P; Xia W; Zhou X; Li Q; Wang X; Chen J; Zeng X; Zhao Z; He H; Liu D; Zhu Z · Hypertension (Dallas, Tex. : 1979) · 2016
    Randomized trial120 participantsCardiovascular Support forTaurine
  2. Taurine ameliorates blood pressure and vascular function in patients with type 2 diabetes: Randomized, double-blind, placebo-controlled trial.
    Li Y; Wang Q; Liu Y; Li Q; Xia W; Lin S; Yang Q; Scholze A; Zhao Z; He H; Zhang H; Yan Z; Tepel M; Mu H; Zhu Z; Liu D · iScience · 2025
    Randomized trial165 participantsCardiovascular Support forTaurine
  3. Taurine reduces the risk for metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials.
    Tzang CC; Chi LY; Lin LH; Lin TY; Chang KV; Wu WT; Özçakar L · Nutrition & diabetes · 2024
    Meta-analysis1,024 participants25 studies pooledCardiovascular Support forTaurine
  4. Effects of Oral Taurine Supplementation on Cardiometabolic Risk Factors: A Meta-analysis and Systematic Review of Randomized Clinical Trials.
    Nie Z; Liu Y; Zhang M; Wu C; Cao Q; Xu J; Zheng Y; Min Z; Zhang W; Han S · Nutrition reviews · 2025
    Meta-analysis34 studies pooledCardiovascular Support forTaurine
  5. The effects of taurine supplementation on glycemic control and serum lipid profile in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
    Maleki V; Alizadeh M; Esmaeili F; Mahdavi R · Amino acids · 2021
    Randomized trial45 participantsCardiovascular Support forTaurine
  6. Taurine supplementation enhances anaerobic power in elite speed skaters: A double-blind, randomized, placebo-controlled, crossover study.
    Buzdağlı Y; Eyipınar CD; Öget F; Şıktar E; Forbes SC; Tekin A · Biology of sport · 2023
    Randomized trial30 participantsFitness forTaurine
  7. The effect of acute taurine ingestion on 3-km running performance in trained middle-distance runners.
    Balshaw TG; Bampouras TM; Barry TJ; Sparks SA · Amino acids · 2013
    Randomized trial8 participantsFitness forTaurine
  8. Effects of different doses of taurine supplementation on repeated-sprint performance after exhaustive exercise in a high temperature and humidity environment.
    Cheng X; Lin Y; Li Z · Frontiers in nutrition · 2026
    Randomized trial16 participantsFitness forTaurine
  9. Oral taurine improves critical power and severe-intensity exercise tolerance.
    Waldron M; Patterson SD; Jeffries O · Amino acids · 2020
    Randomized trial12 participantsFitness forTaurine
  10. Acute taurine supplementation enhances thermoregulation and endurance cycling performance in the heat.
    Page LK; Jeffries O; Waldron M · European journal of sport science · 2019
    Randomized trial11 participantsFitness forTaurine
  11. Oxidative stress and inflammation in obesity after taurine supplementation: a double-blind, placebo-controlled study.
    Rosa FT; Freitas EC; Deminice R; Jordão AA; Marchini JS · European journal of nutrition · 2015
    Randomized trial24 participantsInflammation forTaurine
  12. Effect of taurine supplementation on preventing ventilator-associated pneumonia in pediatrics under mechanical ventilation, a randomized controlled double-blind clinical trial.
    Shirzad-Yazdi N; Shorafa E; Abootalebi SN; Heidari R; Hojabri K; Doostfatemeh M; Masjedi F; Vazin A; Shafiekhani M · Frontiers in pediatrics · 2025
    Randomized trial77 participantsInflammation forTaurine
  13. Effect of taurine in muscle damage markers and inflammatory cytokines in running exercise.
    Wang Y; Xu T; Zhao H; Gu C; Li Z · Frontiers in physiology · 2022
    Non-randomized trial10 participantsInflammation forTaurine
  14. Exercise and taurine in inflammation, cognition, and peripheral markers of blood-brain barrier integrity in older women.
    Chupel MU; Minuzzi LG; Furtado G; Santos ML; Hogervorst E; Filaire E; Teixeira AM · Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme · 2018
    Randomized trial48 participantsInflammation forTaurine
  15. Taurine supplementation has anti-atherogenic and anti-inflammatory effects before and after incremental exercise in heart failure.
    Ahmadian M; Roshan VD; Aslani E; Stannard SR · Therapeutic advances in cardiovascular disease · 2017
    Randomized trialInflammation forTaurine
  16. Dietary amino acid taurine ameliorates liver injury in chronic hepatitis patients.
    Hu YH; Lin CL; Huang YW; Liu PE; Hwang DF · Amino acids · 2008
    Non-randomized trial24 participantsLiver & Detox forTaurine
  17. Taurine status and response to intravenous taurine supplementation in adults with short-bowel syndrome undergoing long-term parenteral nutrition: a pilot study.
    Schneider SM; Joly F; Gehrardt MF; Badran AM; Myara A; Thuillier F; Coudray-Lucas C; Cynober L; Trivin F; Messing B · The British journal of nutrition · 2006
    Single-arm trial32 participantsLiver & Detox forTaurine
  18. Taurine supplementation reduces myeloperoxidase and matrix-metalloproteinase-9 levels and improves the effects of exercise in cognition and physical fitness in older women.
    Chupel MU; Minuzzi LG; Furtado GE; Santos ML; Ferreira JP; Filaire E; Teixeira AM · Amino acids · 2021
    Randomized trial48 participantsLongevity forTaurine
  19. Taurine as a possible antiaging therapy: A controlled clinical trial on taurine antioxidant activity in women ages 55 to 70.
    Abud GF; De Carvalho FG; Batitucci G; Travieso SG; Bueno Junior CR; Barbosa Junior F; Marchini JS; de Freitas EC · Nutrition (Burbank, Los Angeles County, Calif.) · 2022
    Randomized trial24 participantsLongevity forTaurine
  20. Association of taurine intake with changes in physical fitness among community-dwelling middle-aged and older Japanese adults: an 8-year longitudinal study.
    Domoto T; Kise K; Oyama Y; Furuya K; Kato Y; Nishita Y; Kozakai R; Otsuka R · Frontiers in nutrition · 2024
    Cohort studyLongevity forTaurine